David Voreacos

Abbott Laboratories agreed to pay $670 million to settle some lawsuits alleging that it hid the risk that its infant formula for premature babies can cause a deadly bowel disease.

The judge overseeing the Luigi Mangione federal case voiced concern about whether a guilty plea might impact jury selection in the separate murder case he faces in New York state court.

Abbott Laboratories agreed to pay $385 million to settle U.S. allegations related to poor manufacturing practices at two facilities, including one involving an investigation of a contaminated facility that made powder infant formula.

The Trump administration ended its latest effort to block federal funding for the $16 billion Gateway tunnel project connecting New York and New Jersey, dropping an appeal of a court ruling against the US.

The Trump administration ended its latest effort to block federal funding for the $16 billion Gateway tunnel project connecting New York and New Jersey, dropping an appeal of a court ruling against the U.S.

USA Today, Daily Mail General and Trust and a class of large publishers can seek more than $3.2 billion in damages for harm caused by monopolization

USA Today Co., Daily Mail General and Trust Plc and a class of large publishers can seek more than $3.2 billion in damages for harm caused by monopolization of advertising technology markets by Alphabet Inc.'s Google, a New York federal judge ruled.

A Texas felon was charged with running a tax scam that helped wealthy clients hide more than $1.5 billion in income from the IRS, using the proceeds

By A Texas felon was charged with running a tax scam that helped wealthy clients hide more than $1.5 billion in income from the IRS, using

Novo Nordisk A/S lost a bid in a US court to temporarily block Eli Lilly & Co. from using advertisements that claim its drugs are more powerful, a setback to Novo as it battles to regain a larger share of the obesity and diabetes drug markets.